Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 … (Business Wire via Yahoo! Finance) « IPS Cell Therapy

Log in

Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 … (Business Wire via Yahoo! Finance)

Posted in Nano Medicine

February 9th, 2010 by admin

BERKELEY, Calif.—-ExThera Medical announced today that the results of a preliminary study of its proprietary medical device, Seraph™ extracorporeal affinity therapy, have been published in the current issue of the Journal of the American Society for Artificial Organs .

This entry was posted on Tuesday, February 9th, 2010 at 8:12 am and is filed under Nano Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Comments are closed.